ID   LMTK1_HUMAN             Reviewed;        1374 AA.
AC   Q6ZMQ8; O75136; Q6ZN31; Q86X28;
DT   05-SEP-2006, integrated into UniProtKB/Swiss-Prot.
DT   05-SEP-2006, sequence version 2.
DT   12-OCT-2022, entry version 152.
DE   RecName: Full=Serine/threonine-protein kinase LMTK1;
DE            EC=2.7.11.1;
DE   AltName: Full=Apoptosis-associated tyrosine kinase;
DE            Short=AATYK;
DE   AltName: Full=Brain apoptosis-associated tyrosine kinase;
DE   AltName: Full=CDK5-binding protein;
DE   AltName: Full=Lemur tyrosine kinase 1;
DE   AltName: Full=p35-binding protein;
DE            Short=p35BP;
GN   Name=AATK; Synonyms=AATYK, KIAA0641, LMR1, LMTK1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3), AND VARIANT
RP   CYS-703.
RC   TISSUE=Cerebellum, and Thalamus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 49-1374 (ISOFORM 1), AND VARIANT
RP   CYS-703.
RC   TISSUE=Brain;
RX   PubMed=9734811; DOI=10.1093/dnares/5.3.169;
RA   Ishikawa K., Nagase T., Suyama M., Miyajima N., Tanaka A., Kotani H.,
RA   Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. X. The
RT   complete sequences of 100 new cDNA clones from brain which can code for
RT   large proteins in vitro.";
RL   DNA Res. 5:169-176(1998).
RN   [3]
RP   SEQUENCE REVISION.
RX   PubMed=12168954; DOI=10.1093/dnares/9.3.99;
RA   Nakajima D., Okazaki N., Yamakawa H., Kikuno R., Ohara O., Nagase T.;
RT   "Construction of expression-ready cDNA clones for KIAA genes: manual
RT   curation of 330 KIAA cDNA clones.";
RL   DNA Res. 9:99-106(2002).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 786-1374 (ISOFORM 1), AND VARIANT
RP   SER-1266.
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   ALTERNATIVE SPLICING (ISOFORM 2), INTERACTION WITH CDK5, AND
RP   PHOSPHORYLATION.
RX   PubMed=14521924; DOI=10.1016/j.bbrc.2003.08.143;
RA   Honma N., Asada A., Takeshita S., Enomoto M., Yamakawa E., Tsutsumi K.,
RA   Saito T., Satoh T., Itoh H., Kaziro Y., Kishimoto T., Hisanaga S.;
RT   "Apoptosis-associated tyrosine kinase is a Cdk5 activator p35 binding
RT   protein.";
RL   Biochem. Biophys. Res. Commun. 310:398-404(2003).
RN   [6]
RP   TISSUE SPECIFICITY, SUBCELLULAR LOCATION, AND FUNCTION.
RX   PubMed=10837911; DOI=10.1016/s0169-328x(00)00048-6;
RA   Raghunath M., Patti R., Bannerman P., Lee C.M., Baker S., Sutton L.N.,
RA   Phillips P.C., Damodar Reddy C.;
RT   "A novel kinase, AATYK induces and promotes neuronal differentiation in a
RT   human neuroblastoma (SH-SY5Y) cell line.";
RL   Brain Res. Mol. Brain Res. 77:151-162(2000).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-495 AND SER-1262, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [8]
RP   VARIANTS PHE-81; VAL-97; VAL-104; CYS-703; ARG-815; LEU-923; LYS-1160;
RP   SER-1192; SER-1266 AND THR-1332.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: May be involved in neuronal differentiation.
CC       {ECO:0000269|PubMed:10837911}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1;
CC   -!- SUBUNIT: Interacts with CDK5. {ECO:0000269|PubMed:14521924}.
CC   -!- INTERACTION:
CC       Q6ZMQ8; O95747: OXSR1; NbExp=2; IntAct=EBI-2008380, EBI-620853;
CC       Q6ZMQ8; P62136: PPP1CA; NbExp=3; IntAct=EBI-2008380, EBI-357253;
CC       Q6ZMQ8; P36873: PPP1CC; NbExp=3; IntAct=EBI-2008380, EBI-356283;
CC       Q6ZMQ8; Q96N21: TEPSIN; NbExp=3; IntAct=EBI-2008380, EBI-11139477;
CC       Q6ZMQ8-1; Q15078: CDK5R1; NbExp=2; IntAct=EBI-2008436, EBI-746189;
CC       Q6ZMQ8-2; Q15078: CDK5R1; NbExp=6; IntAct=EBI-2008441, EBI-746189;
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000250}; Single-pass type I
CC       membrane protein {ECO:0000250}. Cytoplasm
CC       {ECO:0000269|PubMed:10837911}. Cytoplasm, perinuclear region
CC       {ECO:0000269|PubMed:10837911}. Note=Predominantly perinuclear.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q6ZMQ8-1; Sequence=Displayed;
CC       Name=2; Synonyms=hAATYKs-p35BP;
CC         IsoId=Q6ZMQ8-2; Sequence=VSP_020225, VSP_020226, VSP_020227,
CC                                  VSP_020228;
CC       Name=3;
CC         IsoId=Q6ZMQ8-3; Sequence=VSP_020226, VSP_020227, VSP_020228;
CC   -!- TISSUE SPECIFICITY: Expressed in brain. {ECO:0000269|PubMed:10837911}.
CC   -!- INDUCTION: Up-regulated during apoptosis.
CC   -!- PTM: Autophosphorylated. Phosphorylated by CDK5.
CC       {ECO:0000269|PubMed:14521924}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. {ECO:0000255|PROSITE-ProRule:PRU00159}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK131395; BAD18544.1; -; mRNA.
DR   EMBL; AK131529; BAD18667.1; -; mRNA.
DR   EMBL; AB014541; BAA31616.2; -; mRNA.
DR   EMBL; BC047378; AAH47378.1; -; mRNA.
DR   CCDS; CCDS45807.1; -. [Q6ZMQ8-1]
DR   RefSeq; NP_001073864.2; NM_001080395.2. [Q6ZMQ8-1]
DR   RefSeq; NP_004911.2; NM_004920.2.
DR   AlphaFoldDB; Q6ZMQ8; -.
DR   SMR; Q6ZMQ8; -.
DR   BioGRID; 114984; 60.
DR   IntAct; Q6ZMQ8; 191.
DR   MINT; Q6ZMQ8; -.
DR   STRING; 9606.ENSP00000324196; -.
DR   TCDB; 8.A.23.1.35; the basigin (basigin) family.
DR   iPTMnet; Q6ZMQ8; -.
DR   PhosphoSitePlus; Q6ZMQ8; -.
DR   BioMuta; AATK; -.
DR   DMDM; 114149222; -.
DR   jPOST; Q6ZMQ8; -.
DR   MassIVE; Q6ZMQ8; -.
DR   MaxQB; Q6ZMQ8; -.
DR   PaxDb; Q6ZMQ8; -.
DR   PeptideAtlas; Q6ZMQ8; -.
DR   PRIDE; Q6ZMQ8; -.
DR   ProteomicsDB; 67901; -. [Q6ZMQ8-1]
DR   ProteomicsDB; 67902; -. [Q6ZMQ8-2]
DR   ProteomicsDB; 67903; -. [Q6ZMQ8-3]
DR   Antibodypedia; 2104; 213 antibodies from 27 providers.
DR   DNASU; 9625; -.
DR   Ensembl; ENST00000326724.9; ENSP00000324196.4; ENSG00000181409.14. [Q6ZMQ8-1]
DR   Ensembl; ENST00000374792.6; ENSP00000363924.2; ENSG00000181409.14. [Q6ZMQ8-3]
DR   GeneID; 9625; -.
DR   KEGG; hsa:9625; -.
DR   MANE-Select; ENST00000326724.9; ENSP00000324196.4; NM_001080395.3; NP_001073864.2.
DR   UCSC; uc010dia.4; human. [Q6ZMQ8-1]
DR   CTD; 9625; -.
DR   DisGeNET; 9625; -.
DR   GeneCards; AATK; -.
DR   HGNC; HGNC:21; AATK.
DR   HPA; ENSG00000181409; Tissue enriched (brain).
DR   MIM; 605276; gene.
DR   neXtProt; NX_Q6ZMQ8; -.
DR   OpenTargets; ENSG00000181409; -.
DR   PharmGKB; PA24370; -.
DR   VEuPathDB; HostDB:ENSG00000181409; -.
DR   eggNOG; ENOG502RCHK; Eukaryota.
DR   GeneTree; ENSGT00940000154244; -.
DR   HOGENOM; CLU_004618_1_0_1; -.
DR   InParanoid; Q6ZMQ8; -.
DR   OMA; MACEVSC; -.
DR   OrthoDB; 53680at2759; -.
DR   PhylomeDB; Q6ZMQ8; -.
DR   TreeFam; TF332280; -.
DR   PathwayCommons; Q6ZMQ8; -.
DR   SignaLink; Q6ZMQ8; -.
DR   SIGNOR; Q6ZMQ8; -.
DR   BioGRID-ORCS; 9625; 21 hits in 1104 CRISPR screens.
DR   GeneWiki; AATK; -.
DR   GenomeRNAi; 9625; -.
DR   Pharos; Q6ZMQ8; Tbio.
DR   PRO; PR:Q6ZMQ8; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   RNAct; Q6ZMQ8; protein.
DR   Bgee; ENSG00000181409; Expressed in sural nerve and 181 other tissues.
DR   ExpressionAtlas; Q6ZMQ8; baseline and differential.
DR   Genevisible; Q6ZMQ8; HS.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004672; F:protein kinase activity; IBA:GO_Central.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0004713; F:protein tyrosine kinase activity; IBA:GO_Central.
DR   GO; GO:0007420; P:brain development; IBA:GO_Central.
DR   GO; GO:0038083; P:peptidyl-tyrosine autophosphorylation; IBA:GO_Central.
DR   GO; GO:0006468; P:protein phosphorylation; IBA:GO_Central.
DR   CDD; cd05087; PTKc_Aatyk1; 1.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR042817; LMTK1_c.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR008266; Tyr_kinase_AS.
DR   Pfam; PF07714; PK_Tyr_Ser-Thr; 1.
DR   PRINTS; PR00109; TYRKINASE.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Cytoplasm; Kinase; Membrane;
KW   Nucleotide-binding; Phosphoprotein; Reference proteome;
KW   Serine/threonine-protein kinase; Transferase; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN           1..1374
FT                   /note="Serine/threonine-protein kinase LMTK1"
FT                   /id="PRO_0000248300"
FT   TRANSMEM        32..52
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          125..395
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          542..622
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          667..731
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          765..1195
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1245..1302
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1320..1374
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        678..694
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        862..879
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        895..909
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        975..989
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1073..1090
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1097..1120
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1157..1173
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1268..1289
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1322..1336
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1337..1352
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1353..1374
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        253
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10028"
FT   BINDING         131..139
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         156
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         495
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         1029
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q80YE4"
FT   MOD_RES         1168
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q80YE4"
FT   MOD_RES         1171
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q80YE4"
FT   MOD_RES         1184
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q80YE4"
FT   MOD_RES         1187
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q80YE4"
FT   MOD_RES         1262
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   VAR_SEQ         1..433
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_020225"
FT   VAR_SEQ         468..503
FT                   /note="Missing (in isoform 2 and isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_020226"
FT   VAR_SEQ         897..915
FT                   /note="VGTPDSLDSLDIPSSASDG -> WPQREESLPRLCLLLRPRG (in
FT                   isoform 2 and isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_020227"
FT   VAR_SEQ         916..1374
FT                   /note="Missing (in isoform 2 and isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_020228"
FT   VARIANT         81
FT                   /note="S -> F (in an ovarian mucinous carcinoma sample;
FT                   somatic mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_032679"
FT   VARIANT         97
FT                   /note="L -> V (in a lung adenocarcinoma sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_032680"
FT   VARIANT         104
FT                   /note="M -> V (in an ovarian mucinous carcinoma sample;
FT                   somatic mutation; dbSNP:rs1337040042)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_032681"
FT   VARIANT         118
FT                   /note="T -> M (in dbSNP:rs8082016)"
FT                   /id="VAR_027267"
FT   VARIANT         703
FT                   /note="G -> C (in dbSNP:rs7503604)"
FT                   /evidence="ECO:0000269|PubMed:14702039,
FT                   ECO:0000269|PubMed:17344846, ECO:0000269|PubMed:9734811"
FT                   /id="VAR_032682"
FT   VARIANT         815
FT                   /note="S -> R (in dbSNP:rs56032966)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_032683"
FT   VARIANT         923
FT                   /note="S -> L (in dbSNP:rs56313973)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_032684"
FT   VARIANT         1160
FT                   /note="E -> K (in dbSNP:rs55793641)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_032685"
FT   VARIANT         1192
FT                   /note="P -> S (in dbSNP:rs55856613)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_032686"
FT   VARIANT         1266
FT                   /note="F -> S (in dbSNP:rs36000545)"
FT                   /evidence="ECO:0000269|PubMed:15489334,
FT                   ECO:0000269|PubMed:17344846"
FT                   /id="VAR_032687"
FT   VARIANT         1332
FT                   /note="A -> T (in dbSNP:rs55713566)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_032688"
FT   CONFLICT        49..63
FT                   /note="MLACLCCKKGGIGFK -> HQVKVQGCWGRWRWQ (in Ref. 2)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        511
FT                   /note="A -> T (in Ref. 1; BAD18667)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        541
FT                   /note="A -> T (in Ref. 1; BAD18544)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        557
FT                   /note="T -> I (in Ref. 1; BAD18544)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        786
FT                   /note="A -> V (in Ref. 4; AAH47378)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        790
FT                   /note="T -> A (in Ref. 1; BAD18667)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1028
FT                   /note="P -> R (in Ref. 4; AAH47378)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1271
FT                   /note="P -> H (in Ref. 4; AAH47378)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1324
FT                   /note="P -> R (in Ref. 4; AAH47378)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1360
FT                   /note="K -> E (in Ref. 4; AAH47378)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1374 AA;  144569 MW;  AD46BD688AF7103E CRC64;
     MSSSFFNPSF AFSSHFDPDG APLSELSWPS SLAVVAVSFS GLFAVIVLML ACLCCKKGGI
     GFKEFENAEG DEYAADLAQG SPATAAQNGP DVYVLPLTEV SLPMAKQPGR SVQLLKSTDV
     GRHSLLYLKE IGRGWFGKVF LGEVNSGISS AQVVVKELQA SASVQEQMQF LEEVQPYRAL
     KHSNLLQCLA QCAEVTPYLL VMEFCPLGDL KGYLRSCRVA ESMAPDPRTL QRMACEVACG
     VLHLHRNNFV HSDLALRNCL LTADLTVKIG DYGLAHCKYR EDYFVTADQL WVPLRWIAPE
     LVDEVHSNLL VVDQTKSGNV WSLGVTIWEL FELGTQPYPQ HSDQQVLAYT VREQQLKLPK
     PQLQLTLSDR WYEVMQFCWL QPEQRPTAEE VHLLLSYLCA KGATEAEEEF ERRWRSLRPG
     GGGVGPGPGA AGPMLGGVVE LAAASSFPLL EQFAGDGFHA DGDDVLTVTE TSRGLNFEYK
     WEAGRGAEAF PATLSPGRTA RLQELCAPDG APPGVVPVLS AHSPSLGSEY FIRLEEAAPA
     AGHDPDCAGC APSPPATADQ DDDSDGSTAA SLAMEPLLGH GPPVDVPWGR GDHYPRRSLA
     RDPLCPSRSP SPSAGPLSLA EGGAEDADWG VAAFCPAFFE DPLGTSPLGS SGAPPLPLTG
     EDELEEVGAR RAAQRGHWRS NVSANNNSGS RCPESWDPVS AGGHAEGCPS PKQTPRASPE
     PGYPGEPLLG LQAASAQEPG CCPGLPHLCS AQGLAPAPCL VTPSWTETAS SGGDHPQAEP
     KLATEAEGTT GPRLPLPSVP SPSQEGAPLP SEEASAPDAP DALPDSPTPA TGGEVSAIKL
     ASALNGSSSS PEVEAPSSED EDTAEATSGI FTDTSSDGLQ ARRPDVVPAF RSLQKQVGTP
     DSLDSLDIPS SASDGGYEVF SPSATGPSGG QPRALDSGYD TENYESPEFV LKEAQEGCEP
     QAFAELASEG EGPGPETRLS TSLSGLNEKN PYRDSAYFSD LEAEAEATSG PEKKCGGDRA
     PGPELGLPST GQPSEQVCLR PGVSGEAQGS GPGEVLPPLL QLEGSSPEPS TCPSGLVPEP
     PEPQGPAKVR PGPSPSCSQF FLLTPVPLRS EGNSSEFQGP PGLLSGPAPQ KRMGGPGTPR
     APLRLALPGL PAALEGRPEE EEEDSEDSDE SDEELRCYSV QEPSEDSEEE APAVPVVVAE
     SQSARNLRSL LKMPSLLSET FCEDLERKKK AVSFFDDVTV YLFDQESPTR ELGEPFPGAK
     ESPPTFLRGS PGSPSAPNRP QQADGSPNGS TAEEGGGFAW DDDFPLMTAK AAFAMALDPA
     APAPAAPTPT PAPFSRFTVS PAPTSRFSIT HVSDSDAESK RGPEAGAGGE SKEA
//
